Quince Therapeutics Inc
NASDAQ:QNCX

Watchlist Manager
Quince Therapeutics Inc Logo
Quince Therapeutics Inc
NASDAQ:QNCX
Watchlist
Price: 4.4 USD 10.28% Market Closed
Market Cap: 245m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of QNCX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

QNCX Intrinsic Value
Not Available
Base Case Scenario
Compare QNCX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about QNCX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Quince Therapeutics Inc

Current Assets 29.2m
Cash & Short-Term Investments 26.3m
Receivables 995k
Other Current Assets 1.9m
Non-Current Assets 80.7m
Long-Term Investments 78k
PP&E 1.1m
Intangibles 67.7m
Other Non-Current Assets 11.8m
Current Liabilities 26m
Accounts Payable 3.4m
Accrued Liabilities 5.1m
Other Current Liabilities 17.5m
Non-Current Liabilities 82.8m
Other Non-Current Liabilities 82.8m
Efficiency

Free Cash Flow Analysis
Quince Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Quince Therapeutics Inc

Revenue
0 USD
Operating Expenses
-50.3m USD
Operating Income
-50.3m USD
Other Expenses
-6.7m USD
Net Income
-57m USD
Fundamental Scores

QNCX Profitability Score
Profitability Due Diligence

Quince Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

Quince Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

QNCX Solvency Score
Solvency Due Diligence

Quince Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Quince Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

QNCX Price Targets Summary
Quince Therapeutics Inc

Wall Street analysts forecast QNCX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QNCX is 7.65 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

Lowest
Price Target
4.04 USD
8% Downside
Average
Price Target
7.65 USD
74% Upside
Highest
Price Target
10.5 USD
139% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Quince Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for QNCX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

QNCX Insider Trading
Buy and sell transactions by insiders